Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

Filtrar os resultados da pesquisa
Selecionar modelos de dados

Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

274 Resultados da pesquisa.

Southwest Oncology Group Registration Form (S0500) NCT00382018

- 20/09/2021 - 1 Formulário, 4 Grupos de itens, 36 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Miscellaneous Patient Information, Stratification Factors

Southwest Oncology Group Registration Form (S0500) NCT00382018 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=07BE67DB-E4E8-6CBC-E044-0003BA3F9857

Southwest Oncology Group Registration Form (S0303) NCT00070122

- 20/09/2021 - 1 Formulário, 3 Grupos de itens, 32 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, CCRR MODULE

Southwest Oncology Group Registration Form (S0303) NCT00070122 Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BC61CF50-FD6D-101D-E034-0003BA12F5E7

Southwest Oncology Group Registration Form (S0600) NCT00499369

- 20/09/2021 - 1 Formulário, 3 Grupos de itens, 32 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Miscellaneous Patient Information

Southwest Oncology Group Registration Form (S0600) NCT00499369 Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=15404476-282E-46CA-E044-0003BA3F9857

Breast Cancer NCT00041119 Registration - CALGB 40101 REGISTRATION WORKSHEET - 2670720v1.0 - CALGB 40101 REGISTRATION WORKSHEET

- 17/09/2021 - 1 Formulário, 6 Grupos de itens, 43 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Certification Of Eligibility and Protocol Design, Initial Patient Consent For Specimen Use, Registration Information

Cyclophosphamide and Doxorubicin (CA x 4 cycles) versus Paclitaxel (4 cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2x2 Factorial Phase III Randomized Study Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=36B8E5A6-BC9A-573E-E044-0003BA3F9857

Breast Cancer NCT00785291 Registration - CALGB-40502 Registration Worksheet Form - 2765448v1.0 - CALGB-40502 Registration Worksheet Form

- 17/09/2021 - 1 Formulário, 11 Grupos de itens, 44 Elementos de dados, 1 Idioma

Grupos de itens: Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Pre-Treatment Characteristics, Certification Of Eligibility/Protocol Design, Certification Of Eligibility/Protocol Design, Study 150714: Optional Correlative science companion to 40502 (Separate IRB approval not required.), Study 60704: Optional Pharmacogenomic companion to 40502 (Separate IRB approval not required.), Study 70501 (Optional): Collection of Patient Reported Symptoms and Performance Status via the internet., Registration Information

CALGB-40502 Registration Worksheet Form Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=51FACCD6-7472-0406-E044-0003BA3F9857

Breast Cancer NCT00770809 Registration - CALGB 40601 REGISTRATION WORKSHEET - 2680365v1.0 - CALGB 40601 REGISTRATION WORKSHEET

- 17/09/2021 - 1 Formulário, 9 Grupos de itens, 48 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Certification Of Eligibility, Protocol Design, Initial Patient Consent For Specimen Use, Tissue Procurement Kit, Registration Information

CALGB 40601 REGISTRATION WORKSHEET Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=39E131B2-F4E4-13F1-E044-0003BA3F9857

Colorectal Cancer NCT00726622 Registration - Z6051 - OPEN Enrollment Form - 2967118v1.0 - Z6051 - OPEN Enrollment Form

- 17/09/2021 - 1 Formulário, 9 Grupos de itens, 48 Elementos de dados, 1 Idioma

Grupos de itens: Institution/Protocol combinations, Specify credits, Demographics, General Information, Stratification Factors, Eligibility Criteria, Amendment 4 Approval, Specimen Banking Consent, Randomization

Z6051 - OPEN Enrollment Form Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7AB13387-079D-04A4-E040-BB89AD4319A7

Colorectal Cancer NCT01150045 Registration - CALGB 80702 Registration Worksheet Form - 2969752v1.0 - CALGB 80702 Registration Worksheet Form

- 17/09/2021 - 1 Formulário, 10 Grupos de itens, 47 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Initial Patient Consent For Specimen Use, Notes, Registration Information

CALGB 80702 Registration Worksheet Form Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7AD9533B-3CE6-57A8-E040-BB89AD434546

Breast Cancer NCT00914043 Registration - NSABP B-45 Worksheet for Entry Form - 2846518v1.0 - NSABP B-45 Worksheet for Entry Form

- 17/09/2021 - 1 Formulário, 24 Grupos de itens, 185 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Race, Demographics, Protocol Administration, Cardiac Conditions, Other Conditions, Cardiac Risk Factors, SECTION 2 - Diagnostic, Nodal Status Assessments PRIOR TO NEOADJUVANT CHEMOTHERAPY, SECTION 3 - NEOADJUVANT CHEMOTHERAPY, SECTION 4 - SURGERY AFTER NEOADJUVANT CHEMOTHERAPY, SECTION 4 - SURGERY AFTER NEOADJUVANT CHEMOTHERAPY1, Sentinel Node Biopsy Staging, Other Axillary Staging, Postoperative Chemotherapy, Baseline Values, Patient Characteristics, Baseline Values1, Blood Counts, Baseline Values2, Other, Other1, Other2, Footer Module

NSABP B-45 Worksheet for Entry Form Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6461E18A-2104-98F1-E040-BB89AD4303E7

Breast Cancer NCT00068601 Registration - Southwest Oncology Group Registration Form (S0230) - 2170399v3.0 - Southwest Oncology Group Registration Form (S0230)

- 17/09/2021 - 1 Formulário, 2 Grupos de itens, 27 Elementos de dados, 1 Idioma

Grupos de itens: Stratification Factors, CCRR MODULE

Southwest Oncology Group Registration Form (S0230) Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BEA482FC-617F-0320-E034-0003BA12F5E7

Registration - Phase II Breast Cancer Registration Form - 2550280v1.0 - Phase II Breast Cancer Registration Form

- 17/09/2021 - 1 Formulário, 6 Grupos de itens, 50 Elementos de dados, 1 Idioma

Grupos de itens: Registration Header, Protocol Administration, Patient Demographics / Pre-Treatment Characteristics, Certification of Eligibility, Protocol Design, Initial Patient Consent for Specimen Use

Phase II Breast Cancer Registration Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=23E49B63-1DBC-53B8-E044-0003BA3F9857

Colorectal Cancer NCT00265850 Registration - CALGB 80405 REGISTRATION WORKSHEET - 2672321v1.0 - CALGB 80405 REGISTRATION WORKSHEET

- 17/09/2021 - 1 Formulário, 7 Grupos de itens, 53 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Race, Certification Of Eligibility and Protocol Design, Companion Studies, Registration Information

A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab,or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patientswith Untreated Metastatic Adenocarcinoma of the Colon or Rectum Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=37A89102-B023-3CED-E044-0003BA3F9857

Palavras-chave

Índice

Modelos de dados selecionados

Southwest Oncology Group Registration Form (S0500) NCT00382018

Southwest Oncology Group Registration Form (S0303) NCT00070122

Southwest Oncology Group Registration Form (S0600) NCT00499369

Breast Cancer NCT00041119 Registration - CALGB 40101 REGISTRATION WORKSHEET - 2670720v1.0 - CALGB 40101 REGISTRATION WORKSHEET

Breast Cancer NCT00785291 Registration - CALGB-40502 Registration Worksheet Form - 2765448v1.0 - CALGB-40502 Registration Worksheet Form

Breast Cancer NCT00770809 Registration - CALGB 40601 REGISTRATION WORKSHEET - 2680365v1.0 - CALGB 40601 REGISTRATION WORKSHEET

Colorectal Cancer NCT00726622 Registration - Z6051 - OPEN Enrollment Form - 2967118v1.0 - Z6051 - OPEN Enrollment Form

Colorectal Cancer NCT01150045 Registration - CALGB 80702 Registration Worksheet Form - 2969752v1.0 - CALGB 80702 Registration Worksheet Form

Breast Cancer NCT00914043 Registration - NSABP B-45 Worksheet for Entry Form - 2846518v1.0 - NSABP B-45 Worksheet for Entry Form

Breast Cancer NCT00068601 Registration - Southwest Oncology Group Registration Form (S0230) - 2170399v3.0 - Southwest Oncology Group Registration Form (S0230)

Registration - Phase II Breast Cancer Registration Form - 2550280v1.0 - Phase II Breast Cancer Registration Form

Colorectal Cancer NCT00265850 Registration - CALGB 80405 REGISTRATION WORKSHEET - 2672321v1.0 - CALGB 80405 REGISTRATION WORKSHEET

Palavras-chave

Índice

Modelos de dados selecionados

Contacto

Ajuda